Displaying 1 - 10 of 48
A Randomised Controlled Trial to Evaluate Adding Self-administered Oral HIV testing as a Choice in Clinic and Non-clinic Settings to Increase HIV Testing Uptake Among Truck Drivers in Kenya.
The International Initiative for Impact Evaluation (3IE)
This project is a randomized controlled trial to evaluate HIV test uptake among truck drivers recruited from two roadside wellness clinics in Kenya when offered a choice between the standard, clinic based, provider administered blood based rapid HIV test versus a choice between the standard HIV test or self-administered oral rapid HIV test that can be used in the clinic with supervision or outside the clinic without supervision.
A Randomised Controlled Trial to Increase HIV Testing Demand Among Truck Drivers and Female Sex Workers Through Offering Self-Administered Oral HIV Testing at North Star Alliance Clinics in Kenya.
The International Initiative for Impact Evaluation (3IE)
This study looks at whether advertising self-administered oral HIV test kits to truck drivers and sex workers registered in the North Star alliance electronic medical record system increases HIV testing compared to the standard of texting general HIV testing reminders.
A Social Ecological Model of Infant Sleep Environments among Non-Hispanic Black Infants
This R15 aims to use photo-elicitation interviewing as a form of participatory research in low income urban communities to explore the lived experience of parenting and contextualize infant care practices among three non-Hispanic Black subgroups, and to quantitatively identify socio-cultural and environmental influences on sleep related infant care practices in these communities using audio computer assisted self- interviews to contribute to a social ecological model of infant sleep environments.
Applied Statistics for High-throughput Biology; Enhanced Estimation of the Cancer Proteome from Transcriptome Assays.
US Department of State, Fulbright
The major goal of Dr. Waldron’s U.S. Fulbright grant to Italy was to bridge gaps between high-throughput biology and public health, and bring together the University of Trento and CUNY on topics of common interest. Dr. Waldron completed his Fulbright grant January - June 2016.
Cancer genomics: integrative and scalable solutions in R/Bioconductor
The major goals of this project are to develop scalable R / Bioconductor software infrastructure and data resources to integrate complex, heterogeneous, and large cancer genomic experiments. The falling cost of genomic assays facilitates collection of multiple data types (e.g., gene and transcript expression, structural variation, copy number, methylation, and microRNA data) from a set of clinical specimens. Furthermore, substantial resources are now available from large consortium activities like The Cancer Genome Atlas (TCGA). Existing analysis pipelines focus on the treatment of a specific data type, leaving a critical need for tools for integrative analysis of multiple genomic assays for locally generated or publicly available data. This proposal adapts R / Bioconductor to meet the increasing conceptual and computational complexity of multi-assay cancer genomic experiments. PMID: 26463000, 25633503
Club Drug Use and PrEP Adherence in Vulnerable Men
This study investigates the association between club drug use (ketamine, ecstasy, GHB, cocaine, methamphetamine) and adherence to PrEP in a sample of 100 gay and bisexual men. Participants complete prospective and retrospective assessment.
Collaboration on HIV and Aging Research – Hudson Valley
Dr. Baim-Lance leads the research component for the Collaboration on HIV and Aging Research-Hudson Valley (CAHAR-HV). CAHAR-HV is made up of a diverse group of stakeholders of patients, providers, government agencies and researchers, working together to develop projects that improve the care for older individuals with HIV. CAHAR-HV is in the process of developing feasible, scaled-up implementation science studies on issues pertinent to HIV and aging using community-based, participatory research methods. CAHAR-HV is supported with a Pipeline to Proposal Award from the Patient Center Outcomes Research Institute (PCORI).
Combined effects of provider and insurer market concentration on hospital costs
There is a consensus in the literature that provider – generally hospital – concentration causes higher commercial medical prices. Newer literature has examined the supply side of the market to examine whether concentrated insurers successfully lower premiums. But there is almost no research connecting these two literatures, investigating the combined dynamics of provider and insurer concentration on costs and premiums. This project investigates whether the association of provider market concentration and hospital costs and insurance premiums differs by insurance market competitiveness.
Costs, Health Outcomes and Real-world Determinants of Success in HIV Care Coordination (CHORDS)
This study aims to assess the effectiveness of the NYC Ryan White comprehensive HIV Care Coordination Program (CCP) relative to that of usual care outside the CCP for persons living with HIV and residing in NYC, to determine what individual and program-level factors are associated with optimal care outcomes for CCP participants and to determine the cost-effectiveness of the CCP relative to usual care outside the CCP. Through this work, CHORDS is generating much-needed evidence related to the effectiveness, outcome determinants and cost-effectiveness of a promising, scalable service delivery strategy, ultimately increasing the capacity of HIV care programs to achieve the greatest possible uptake and impact. The project is a collaboration between the CUNY ISPH, the New York City Department of Health and Mental Hygiene, and New York University Section on Value and Effectiveness (SOLVE).
Developing and Testing a Brief Sero-adaptive Assessment Tool for Use with Vulnerable Men
The Centers for Disease Control and Prevention Special Interest Project Competitive Supplement (SIPS)
This study developed and tested a new measure of sero-adaptive behaviors being used by men who have sex with men to reduce HIV transmission risk. The study used formative research to develop a brief clinical tool to ascertain seroadaptive behaviors among HIV+ and HIV- MSM and pilot test the tool to assess seroadaptive practices, condom use, and HIV testing among MSM in clinical and outreach settings. In Phase 1, qualitative methods were used to develop the measure. In Phase 2, the measure was tested in both clinical and outreach settings with a racially and ethnically diverse sample of 5000+ MSM from across the U.S.